Brain Biotechnology Research and Information Network AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Brain Biotechnology Research and Information Network AG with three other
miscellaneous service companies in Europe:
of the United Kingdom
sales of £20.79 million [US$28.96 million]
of which 69%
was Research and development),
(29.60 million Euro [US$36.36 million]
Veloxis Pharmaceuticals A/S
based in Denmark
(196.99 million Danish Kroner [US$32.47 million]
of which 100%
was Pharmaceutical Preparations).
Brain Biotechnology Research and Information Network AG reported sales of 26.42 million Euro (US$32.45 million)
September of 2017.
increase of 5.5%
versus 2016, when the company's sales were 25.04 million Euro.
Sales at Brain Biotechnology Research and Information Network AG have increased during each of the previous five years
(and since 2012, sales have increased a total of 263%).
Sales of Bioscience saw an increase
8.9% in 2017, from
9.78 million Euro to 10.65 million Euro.